Skip to main content
. 2022 Apr 27;13:791439. doi: 10.3389/fendo.2022.791439

Table 6.

Clinical characteristics of patients with subdivided premixed insulin group.

Premixed Insulin HbA1c<7%
(N=68)
HbA1c≥7%
(N=126)
p value
Age (years) 63.09 ± 9.32 63.15 ± 9.09 0.86
Fasting C-peptide (ng/ml) 1.32 ± 0.09 1.43 ± 0.10 0.48
Ins-Ab (COI) 17.01 ± 2.27 18.36 ± 1.73 0.64
Duration of T2DM (years) 12.75 ± 6.92 14.07 ± 6.82 0.20
Duration of insulin (years) 7.91 ± 6.78 7.59 ± 5.95 0.73
Insulin dose (IU/kg/day) 0.49 ± 0.02 0.47 ± 0.02 0.63

Data was shown as mean ± SD. HbA1c, glycated haemoglobin; Ins-Ab, insulin antibody; COI, OD/CO; OD, absorbance; CO, average absorbance of negative control; The reference range of normal values for antibody is <1 COI.